Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-08

Clinical Trial Update: Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Xoçai antioxidant supplements on atherosclerosis risk factors in participants with hypertension, dyslipidem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xoçai Antioxidant Supplements

Snippet

Sponsor: University of Utah | Conditions: Hypertension, Dyslipidemia | NA | Status: COMPLETED